Sunshine Heart Inc  

(Public, ASX:SHC)   Watch this stock  
Find more results for SHC
- Close
ASX data delayed by 20 mins - Disclaimer
Currency in
Range     -
52 week 0.02 - 0.06
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -1.81
Shares     -
Beta     -
Inst. own     -
May 5, 2015
Q1 2015 Sunshine Heart Inc Earnings Release
May 5, 2015
Q1 2015 Sunshine Heart Inc Earnings Call
Mar 18, 2015
Q4 2014 Sunshine Heart Inc Earnings Call
Mar 17, 2015
Q4 2014 Sunshine Heart Inc Earnings Release
Mar 5, 2015
Sunshine Heart Inc at Cowen Health Care Conference

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -11971.19% -8673.56%
Operating margin -11850.85% -8741.35%
EBITD margin - -8647.46%
Return on average assets -79.61% -58.42%
Return on average equity -95.57% -63.22%
Employees 54 -
CDP Score - -


12988 Valley View Rd
EDEN PRAIRIE, MN 55344-3657
United States - Map
+1-952-3454200 (Phone)
+1-302-6365454 (Fax)

Website links


Sunshine Heart, Inc. is an early-stage medical device company focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. The C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. As of December 31, 2013, the Company was in the process of obtaining regulatory approvals necessary to sell its system in the United States. The Company has developed tools to allow the C-Pulse to be implanted through a small pacemaker-like incision between the patient’s ribs and sternum rather than a sternotomy

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 66
David A. Rosa President, Chief Executive Officer, Director
Age: 51
Claudia Drayton Chief Financial Officer, Secretary
Age: 47
Debra J. Kridner Executive Vice President - Clinical Research & Regulatory Affairs
Age: 63
Brian Brown Senior Vice President - Operations and Technology
Age: 53
Kimberly Oleson Senior Vice President - Clinical Affairs
Age: 51
Molly Wade Vice President, Worldwide Patient Recruitment and Marketing
Age: 36
Paul R. Buckman Independent Director
Age: 59
Jon W. Salveson Independent Director
Age: 50
Gregory D. Waller Independent Director
Age: 65